SV

Street Verdict

Analyst Scorecard

A record of what Gaurav Garg said publicly, with the source. Not advice.

Pending — not yet graded
“Neutral on Sanofi Consumer shares, advising against chasing the immediate post-results rally. Investors should wait for consolidation before considering fresh exposure. Existing investors can hold if their thesis is intact, but should reassess if the stock fails to sustain recovery. The ₹3,320–₹3,350 zone is immediate support, and ₹3,480–₹3,500 is near-term resistance. Sustained move above resistance improves recovery outlook, while a break below support indicates returning selling pressure. Consistent earnings expansion and sustained double-digit sales growth are key for a more attractive risk-reward.”
Sanofi Consumer Healthcare India LimitedNeutralCalled 29 Oct 2026
Verdict:PENDING

How this conditional call is judged

A conditional call says nothing until a daily close goes beyond a level the quote states. The first side to fire is judged on its own target, which has to be reached on a close. If neither side fires within the window, or the side that fires has no target of its own, the call is not graded and counts toward no hit rate.

Up side: a close above ₹3,500; no target given for this side, so if it fires first the call is not graded.

Down side: a close below ₹3,320; no target given for this side, so if it fires first the call is not graded.

Waiting: no close has gone beyond either level yet.

This call has no verdict yet — it is graded HIT or MISS against real price data once a close decides it. Save it above to find it again from your profile.

Read the original articleSee Gaurav Garg’s full track record